Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinsons disease: mechanisms of action
That GLP-1/GCGR co-agonism can improve glucose, lipid and energy metabolism has subsequently also been demonstrated in human studies [116, 117], and a series of co-agonists have advanced to clinical development for the treatment of type 2 diabetes, non-alcoholic steatohepatitis and obesity (as reviewed previously [117])
Caturano A, et al
So how do you do that
US$ 21.93
US$ 20.28
US$ 20.25
US$ 23.59
US$ 29.01
US$ 21.52
US$ 29.62
